Innocoll receives 'Intends to Grant' notices from the
European Patent Office for wound healing.
Innocoll, Inc. (Ashburn, VA) announced that its wholly-owned
subsidiary, Syntacoll AG, has been notified that pursuant to Rule 51(4)
EPC, the European Patent Office intends to grant two of . . .
Vermillion announces issuance of patent covering method for
aiding diagnosis of kidney disorder.(Brief article)
Vermillion, Inc. (Fremont, CA) announced that the United States
Patent and Trademark Office has issued Vermillion United States Patent
7,297,556 for aiding diagnosis of nephrotic syndrome, a kidney . . .
NanoLogix files multiple international patent applications for
BioNanoChannel and hydrogen bioreactor technology.
NanoLogix, Inc. (Hubbard, OH) a nano-biotechnology company, has
submitted international patent applications for BioNanoChannel and
Hydrogen Bioreactor technology protection for China, India, . . .
United States Patent and Trademark Office allows CRi's
patent application for spectral imaging of deep tissue.
Cambridge Research & Instrumentation (Woburn, MA)) announced
that the United States Patent and Trademark Office has issued a notice
of allowance for their patent application number 10/669,101, . . .
Vaccinex announces award of key patent in Europe for its antibody
discovery technology.
Vaccinex, Inc. (Rochester, NY) announced the award of a key
European patent (European Patent 1340088) for its antibody discovery
technology platform, branded as ActivMab Technology. Vaccinex is . . .
SuperArray Bioscience licenses RNA interference patent from The
Carnegie Institution.
SuperArray Bioscience Corporation (Frederick, MD) has entered into
a RNA Interference (RNAi) license agreement with The Carnegie
Institution. Under the agreement, SuperArray Bioscience Corporation . . .
ARIUS announces manufacturing agreement with Avid Bioservices for
CD44 Cancer Stem Cell antibody - Pre-IND meeting with FDA sche
ARIUS Research, Inc. (Toronto, Canada), a biotechnology company
discovering and developing antibody therapeutics, has entered into a
manufacturing supply and technology transfer agreement for its . . .
Amarin signs agreement to acquire Ester Neurosciences.
Amarin Corporation plc (London, England) has signed an agreement to
acquire Ester Neurosciences Limited (Israel), a private research and
development company. The initial consideration is $15 . . .
Panacea announces selection of PAN-622 - a fully human sequence
monoclonal antibody against HAAH - as its lead cancer therapeuti
Panacea Pharmaceuticals, Inc. (Gaithersburg, MD) announced the
selection of PAN-622 -- a fully human sequence monoclonal antibody
against HAAH -- as its lead cancer therapeutic product. Developed . . .
StemCor systems announces acquisition of intellectual property to
enhance bone marrow aspiration platform.
StemCor Systems, Inc. (Menlo Park, CA) a medical device company
developing systems for Enabling Regenerative Medicine, has acquired
United States Patent 6,849,051, "Devices And Methods For . . .
Decision Biomarkers awarded patent for protein array surface
chemistry.
Decision Biomarkers, Inc. (Waltham, MA), a leading developer of
protein biomarker analysis systems for pharmaceutical research and
development, announced the company's PATH technology has . . .
Oncolytics Biotech announces issuance of 25th patent.
Oncolytics Biotech, Inc. (Calgary, Canada) announced that it has
been granted United States Patent 7,306,902 entitled "Oncolytic
Viruses as Phenotyping Agents for Neoplasms." The claims . . .
Rosetta selects PCR as platform for its microRNA-based
diagnostics to be launched in 2008.
Rosetta Genomics, Ltd. (Rehovot, Israel) has selected the
technological platform for its line of microRNA-based diagnostic
products, the first of which are expected to launch in 2008. The . . .
Start Licensing further strengthens position in cloning industry
with new patents new patents announced for methods of cloning l
Start Licensing, Inc. (Austin, TX) announced that the United States
Patent and Trademark Office has granted United States Patents 7,304,204
and 7,307,198 covering methods of cloning ungulate . . .
Odyssey Thera granted United States Patent for animal
imaging.
Odyssey Thera, Inc. (San Ramon, CA) announced that the United
States Patent and Trademark Office granted United States Patent
7,306,914, entitled "Protein-fragment Complementation Assays in
whole . . .
New partnership means dramatic energy savings for ethanol
plants.
Interstate Power and Light Company (Cedar Rapids, IA), a subsidiary
of Alliant Energy Corporation, Harris Companies (St. Paul MN), a
mechanical contracting firm; and AE&E - Von Roll, Inc., a . . .
Rosetta Columbia University Medical Center to develop
microRNA-based diagnostics for leukemia and non hodgkin
lymphoma.
Rosetta Genomics, Ltd. (Rehovot, Israel) and Columbia University
Medical Center (New York, NY) will collaborate to develop microRNA-based
diagnostic tests, early detection as well as prognosis, for . . .
California drug and alcohol clinic becomes the first in the
nation to offer DNA-customized treatment for individuals with a gene
A Better Tomorrow (Murrieta,,CA) is the first drug and alcohol
treatment center in the nation to offer its patients HAVEOS, a
DNA-customized program for individuals with a genetic predisposition . . .
United States Department of Health and Human Services obtains
United States patent.
United States Department of Health and Human Services (Washington,
DC) has patented a chimeric parainfluenza viruses (PIVs) that
incorporate a PIV vector genome or antigenome and one or more . . .
Myriad Genetics obtains United States patent.
Myriad Genetics, Inc. (Salt Lake City, UT) and University of Utah
(Salt Lake City, UT) have patented methods and materials used to isolate
and detect a human obesity and diabetes predisposing gene, . . .
|
|